0001437749-22-022307.txt : 20220913 0001437749-22-022307.hdr.sgml : 20220913 20220913160744 ACCESSION NUMBER: 0001437749-22-022307 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220909 FILED AS OF DATE: 20220913 DATE AS OF CHANGE: 20220913 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Rosol Michael Stanley CENTRAL INDEX KEY: 0001762349 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35076 FILM NUMBER: 221240822 MAIL ADDRESS: STREET 1: 4995 BRADENTON AVENUE, SUITE 240 CITY: DUBLIN STATE: OH ZIP: 43017 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NAVIDEA BIOPHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000810509 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 311080091 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4995 BRADENTON AVENUE STREET 2: SUITE 240 CITY: DUBLIN STATE: OH ZIP: 43017 BUSINESS PHONE: 6147937500 MAIL ADDRESS: STREET 1: 4995 BRADENTON AVENUE STREET 2: SUITE 240 CITY: DUBLIN STATE: OH ZIP: 43017 FORMER COMPANY: FORMER CONFORMED NAME: NEOPROBE CORP DATE OF NAME CHANGE: 19940714 4 1 rdgdoc.xml FORM 4 X0306 4 2022-09-09 0000810509 NAVIDEA BIOPHARMACEUTICALS, INC. NAVB 0001762349 Rosol Michael Stanley 4995 BRADENTON AVE., SUITE 240 DUBLIN OH 43017 1 Chief Medical Officer Common Stock 2022-09-09 4 A 0 28150 0 A 42725 D Common Stock 2022-09-09 4 A 0 13000 0 A 55725 D Common Stock 11320 I Held by 401(k) Plan The Reporting Person elected to receive stock in lieu of a cash bonus. The number of shares was determined based on the closing price on the date of grant, September 9, 2022. Stock Issued under the Amended and Restated 2014 Stock Incentive Plan. /s/ Erika L. Eves for Michael S. Rosol, by power of attorney 2022-09-13